ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy faster, with greater comfort, and treatment effectiveness. Its flagship products are the ProSomnus [IA] and MicrO2 Sleep, and Snore Devices. Its devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects, and enable dentists to achieve excellent patient experiences and outcomes. The company was founded in 2016 and is headquartered in Pleasanton, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2022 | Post-IPO Equity | $10M | — | — | — | Detail |
Dec 7, 2022 | Post-IPO Debt | $30M | 2 | Cohanzick Management CrossingBridge Advisors | — | Detail |
Dec 7, 2022 | IPO | $125M | — | — | — | Detail |
Aug 9, 2019 | Debt Financing | $50K | — | — | — | Detail |
May 12, 2017 | Series Unknown | $9.17M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cohanzick Management | Yes | Post-IPO Debt |
CrossingBridge Advisors | Yes | Post-IPO Debt |